Case Intake
A confidential
A confidential
readiness review.
Ten minutes of your information, reviewed with discretion. We reply with an honest view of whether OTCQB is worth pursuing — and what would stand in the way.
Ten minutes of your information, reviewed with discretion. We reply with an honest view of whether OTCQB is worth pursuing — and what would stand in the way.
What happens next
Your intake is reviewed confidentially. If OTCQB or OTCQX appears viable, we outline the readiness gaps and the professionals your case would require. If it does not, we say so plainly — before you spend.
Confidentiality
Intake details are used only to assess your case. We do not sell data, run advertising trackers, or publish client identities.
OTC listing is not automatic and financing is not guaranteed. Form 211 is filed by a qualified market maker — a FINRA-member broker-dealer — not by the issuer and not by us. OTC IPO Expert is not a broker-dealer, law firm, auditor, transfer agent, or investment adviser. Our role is readiness assessment, diligence, documentation, and coordination with licensed professionals.